Privia Health Group (Privia Health Group) GF Value : $37.48 (As of Jun. 09, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Privia Health Group GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-06-09), Privia Health Group's share price is $17.15. Privia Health Group's GF Value is $37.48. Therefore, Privia Health Group's Price-to-GF-Value for today is 0.46.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Privia Health Group is Significantly Undervalued.

Privia Health Group (NAS:PRVA) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Privia Health Group's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	17.15	/	37.48
	=	0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Privia Health Group GF Value Related Terms

Thank you for viewing the detailed overview of Privia Health Group's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Privia Health Group (Privia Health Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Privia Health Group Inc (NAS:PRVA) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

950 N. Glebe Road, Suite 700, Arlington, VA, USA, 22203

Website

https://www.priviahealth.com

Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.

Executives

William M Sullivan	director	ONE PENN PLAZA, SUITE 5300, NY NY 10119
Thomas Bartrum	officer: EVP, General Counsel	950 N. GLEBE RD., SUITE 700, ALEXANDRIA VA 22203
Pamela O Kimmet	director	11207 ORANGE HIBISCUS LANE, PALM BEACH GARDENS FL 33418
David S Wichmann	director	BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752
Parth Mehrotra	officer: President and COO	950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Adam Boehler	director	1215 5TH AVE N,, NASHVILLE TN 37208
Matthew Shawn Morris	director, officer: Chief Executive Officer	950 N. GLEBE ST., SUITE 700, ARLINGTON VA 22203
Goldman Sachs Group Inc	10 percent owner	200 WEST STREET, NEW YORK NY 10282
Jeffrey Daniel Bernstein	director	200 WEST STREET, NEW YORK NY 10282
Pamplona Capital Partners Iii, L.p.	10 percent owner	94 SOLARIS AVENUE, CAMANA BAY, P.O. BOX 1348, GRAND CAYMAN E9 KY1-1108
Mbd Advisors, L.l.c.	10 percent owner	200 WEST STREET, NEW YORK NY 10282
David Mountcastle	officer: Chief Financial Officer	950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Jeffrey B Butler	director	950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22101
David P King	director	PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Patricia Anne Maryland	director	7342 HORIZON DRIVE, WEST PALM BEACH FL 33412